Back to funds

DIADEMA PARTNERS LP

Updated 6 days ago

Managed by Diadema Partners Lp • Latest filing Q3 2026

Portfolio value
$780.5M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
34.5%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$580.5M
Q1 2026$587.7M
Q2 2026$791.3M
Q3 2026$780.5M

Top holdings

148 positions as of Q3 2026

View filing
V

VIKING THERAPEUTICS INC

Value
$44.4M
Shares
1.36M
% Port
5.69%
C

BRISTOL-MYERS SQUIBB CO

Value
$37.4M
Shares
600.0K
% Port
4.80%
V

VIKING THERAPEUTICS INC

Value
$37.1M
Shares
1.14M
% Port
4.76%
?
4.N/A

VIKING THERAPEUTICS INC

Value
$32.6M
Shares
1.00M
% Port
4.18%
K

KODIAK SCIENCES INC

Value
$28.2M
Shares
297.0K
% Port
3.61%
U

UNITED THERAPEUTICS CORP DEL

Value
$25.7M
Shares
47.5K
% Port
3.30%
U

UNITED THERAPEUTICS CORP DEL

Value
$25M
Shares
46.2K
% Port
3.21%
B

BIONTECH SE

Value
$24.6M
Shares
250.0K
% Port
3.15%
K

KODIAK SCIENCES INC

Value
$23.9M
Shares
251.7K
% Port
3.06%
C

BRISTOL-MYERS SQUIBB CO

Value
$20.6M
Shares
330.6K
% Port
2.64%
C

COGENT BIOSCIENCES INC

Value
$20.6M
Shares
641.9K
% Port
2.63%
G

GENMAB A/S

Value
$18.5M
Shares
518.1K
% Port
2.37%
K

KYMERA THERAPEUTICS INC

Value
$18M
Shares
160.9K
% Port
2.30%
A

ABIVAX SA

Value
$17.7M
Shares
178.4K
% Port
2.27%
B

BRIDGEBIO PHARMA INC

Value
$16.4M
Shares
250.0K
% Port
2.11%
S

SUMMIT THERAPEUTICS INC

Value
$16.2M
Shares
960.2K
% Port
2.08%
B

BIOMARIN PHARMACEUTICAL INC

Value
$15.3M
Shares
255.4K
% Port
1.96%
R

REVOLUTION MEDICINES INC

Value
$14.4M
Shares
70.0K
% Port
1.84%
N

NOVARTIS AG

Value
$14.3M
Shares
100.0K
% Port
1.83%
V

VIKING THERAPEUTICS INC

Value
$14.1M
Shares
433.2K
% Port
1.81%

Explore